维普中文期刊产品整合服务
31篇 您的检索式:作者名="AMESSOU M"
    题名 作者 年代 出处 被引量
1Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mam- moplasties显示文摘PAGE M J AMESS B TOWNSEND R R 1999Proc Natl Acad Sci U S A1999,96,12:1
2The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Thl-dominant polarization显示文摘HAICHEUR N BENCHETRIT F AMESSOU M 2003Int Immunol2003,15,10:1
3Frequent inframe somatic deletions activate gp130 in inflammatory hepatocellular tumours显示文摘Rebouissou S Amessou M Couchy G 2009Nature2009,457,7226:1
4Proteomics:a major new technology for the drug discovery process显示文摘Page M J Amess B Rohlff C 1999Drug Discovery Today1999,4,:1
5Proteomics: a major new technology for the drug discovery process 显示文摘Page M J Amess B Rohlff C 1999Drug Discov Today1999,4,2:1
6Role of the EphB2 receptor in autophagy, apoptosis and invasion in human breast cancer cells显示文摘Chukkapalli S Amessou M Dilly A K 2014Exp Cell Res2014,320,2:1
7Frequent in-frame somatic deletions activate gpl30 in inflammatory hepatoeellular tumours 显示文摘Rebouissou S Amessou M Couehy G 2009Nature2009,457,7226:1
8The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization显示文摘Haicheur N Benchetrit F Amessou M 2003Int Immunol2003,15,10:1
9The Wage and Employment Effects of Leveraged Buyouts in the UK显示文摘Amess K Wright M 2007International Journal of the Econom- ics of Business2007,,14:1
10Frequent in-frame somatic deletions activate gp130in inflammatory hepatocellular tumours显示文摘Rebouissou S Amessou M Couchy G 2009Nature2009,457,7226:1
11Proteomics:a major new technology for the drug discovery process显示文摘Page M J Amess B Rohlff C 1999Drug Discovery Today1999,4,2:1
12Clathrin adaptor epsinR is required for retrograde sorting on early endosomal membranes 显示文摘Saint-Pol A Ylamos B Amessou M 2004Dev Cell2004,6,4:1
13Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours显示文摘REBOUISSOU S AMESSOU M COUCHY G 2009Nature2009,457,:1
14Fre?quent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours显示文摘REBOUISSSOU S AMESSOU M COUCHY G et at 2009Nature2009,457,7226:1
15Proteomics:a major new technology for the drug discovery process显示文摘Page M J Amess B Rohlff C 1999Drug Discovery Today1999,4,2:1
16Agency, strategic entrepreneurship and the performance of private equity-backed buyouts显示文摘Meuleman M Amess K Wright M and Scholes L 2009Entrepreneurship Theory and Practice2009,33,1:1
17Frequent in - frame somatic deletions activate gpl30 in inflammatory hepato- cellular tumours 显示文摘REBOUISSOU S AMESSOU M COUCHY G 2009Nature2009,457,7226:1
18Proteomics:a major new technology for the drug discovery process 显示文摘Page M J Amess B Rohlff C 1999Drug Discovery Today1999,4,:1
19Private equity and corporategovernance: retrospect and prospect 显示文摘Wright M Amess K Weir C 2009Corporate Governance :an International Review2009,17,3:1
20Proteomics:a major new technology for the drug discovery process显示文摘PAGE M J AMESS B ROHLFF C 1999Drug Discov Today1999,4,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费